Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
Weimin He, Yaacov Barak, Andrea Lynn Hevener et al. · Proceedings of the National Academy of Sciences · 2003
Syndrome X, typified by obesity, insulin resistance (IR), dyslipidemia, and other metabolic abnormalities, is responsive to antidiabetic thiazolidinediones (TZDs). Peroxisome proliferator-activated receptor (PPAR) gamma, a target of TZDs, is expressed abundantly in adipocytes, suggesting an important role for this tissue in the etiology and treatment of IR. Targeted deletion of PPARgamma in adipose tissue resulted in marked adipocyte hypocellularity and hypertrophy, elevated levels of plasma free fatty acids and triglyceride, and decreased levels of plasma leptin and ACRP30. In addition, increased hepatic glucogenesis and IR were observed. Despite these defects, blood glucose, glucose and insulin tolerance, and insulin-stimulated muscle glucose uptake were all comparable to those of control mice. However, targeted mice were significantly more susceptible to high-fat diet-induced steatosis, hyperinsulinemia, and IR. Surprisingly, TZD treatment effectively reversed liver IR, whereas it failed to lower plasma free fatty acids. These results suggest that syndrome X may be comprised of separable PPARgamma-dependent components whose origins and therapeutic sites may reside in distinct tissues.
Cited by 976 works. doi:10.1073/pnas.2536828100 Open-access PDF
Authors
- Weimin He
- Yaacov Barak
- Andrea Lynn Hevener
- Peter Olson
- Debbie Liao
- Jamie Le
- Michael C. Nelson
- Estelita S. Ong
- Jerrold M. Olefsky
- Ronald M. Evans
References
- Generalized lacZ expression with the ROSA26 Cre reporter strain
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
- The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
- The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
- Adipogenesis and Obesity: Rounding Out the Big Picture
- Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
- PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.